Senate Bill 68 aims to amend the prescription drug monitoring program (PDMP) in Wisconsin by extending certain requirements related to the review of patient records and the evaluation of the program's outcomes. Specifically, the bill extends the requirement for practitioners to review a patient's records before issuing a prescription order from April 1, 2025, to April 1, 2030. Additionally, it extends the mandate for the Controlled Substances Board to conduct a quarterly review of the PDMP's actual outcomes compared to projected outcomes from October 30, 2025, to October 30, 2030.

The proposed changes are intended to enhance the oversight and effectiveness of the PDMP, ensuring that practitioners continue to assess patient records before prescribing monitored drugs and that the board regularly evaluates the program's performance. The amendments reflect a commitment to maintaining rigorous standards in prescription drug management and addressing substance abuse concerns in the state.

Statutes affected:
Bill Text: 961.385(2)(cs)1, 961.385, 961.385(5)(b), 961.385(6)(a)
Text as Enrolled: 961.385(2)(cs)1, 961.385, 961.385(5)(b), 961.385(6)(a)